Nagi R, Reddy-Kantharaj Y-B, Rakesh N, Janardhan-Reddy S, Sahu S
Department of oral Medicine and Radiology, New Horizon Dental, College and Research Institute, Sakri, Bilaspur,
Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21(4):e447-55. doi: 10.4317/medoral.21104.
Earlier detection of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD) is essential for dental professionals to improve patient survival rates. The aim of this systematic review is to to evaluate the effectiveness of devices that utilise the principles of chemiluminescence and tissue autofluorescence as adjuncts in the detection of OSCC and OPMD.
The electronic retrieval systems and databases searched for relevant articles were PubMed [MEDLINE] and Science direct. The search was for limited articles published in English or with an English abstract and articles published during the period from January 2005 to April 2014. Clinical trials utilized ViziLite, Microlux TM/DL and Visual Enhanced Light scope (VELscope) for early detection of OPMD and OSCC.
Twenty primary studies published satisfied our criteria for selection - 10 utilised chemiluminescence and 10 tissue autofluorescence. Senstivity of Vizilite for detecting OSCC nad OPMD ranged from 77.1 % to 100% and specificity was low that ranged from 0% to 27.8%.Most have shown that chemiluminescence increases the brightness and margins of oral mucosal white lesions and thus assist in identification of mucosal lesions not considered under Conventional visual examination. However, it preferentially detects leukoplakia and may fail to spot red patches. Clinical trials demonstrated that sensitivity of VELscope in detecting malignancy and OPMD ranged from 22 % to 100 % and specificity ranged from 16 % to 100%. Most studies concluded that VELscope can help the experienced clinician to find oral precursor malignant lesions. But it couldnot differentiate between dysplasia and benign inflammatory conditions.
Both devices are simple, non-invasive test of the oral mucosa but are suited for clinicians with sufficient experience and training. More clinical trials in future should be conducted to establish optical imaging as an efficacious adjunct tool in early diagnosis of OSCC and OPMD.
早期发现口腔鳞状细胞癌(OSCC)和口腔潜在恶性疾病(OPMD)对于牙科专业人员提高患者生存率至关重要。本系统评价的目的是评估利用化学发光和组织自发荧光原理作为辅助手段检测OSCC和OPMD的设备的有效性。
检索的电子检索系统和数据库为PubMed [MEDLINE]和Science direct。检索范围为2005年1月至2014年4月期间发表的英文或有英文摘要的有限文章。临床试验使用ViziLite、Microlux TM/DL和视觉增强光镜(VELscope)早期检测OPMD和OSCC。
发表的20项主要研究符合我们的选择标准——10项利用化学发光,10项利用组织自发荧光。Vizilite检测OSCC和OPMD的敏感性范围为77.1%至100%,特异性较低,范围为0%至27.8%。大多数研究表明,化学发光可增加口腔黏膜白色病变的亮度和边界,从而有助于识别传统视觉检查未考虑的黏膜病变。然而,它优先检测白斑,可能无法发现红色斑块。临床试验表明,VELscope检测恶性肿瘤和OPMD的敏感性范围为22%至100%,特异性范围为16%至100%。大多数研究得出结论,VELscope可帮助经验丰富的临床医生发现口腔前驱恶性病变。但它无法区分发育异常和良性炎症情况。
这两种设备都是对口腔黏膜的简单、非侵入性检测,但适合有足够经验和培训的临床医生。未来应进行更多临床试验,以确立光学成像作为OSCC和OPMD早期诊断的有效辅助工具。